The global Rotavirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Rotavirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rotavirus Infections Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rotavirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rotavirus Infections Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
Curevac AG
Medicago Inc
Nanotherapeutics Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Institute of Biological Products Co Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
RV-3BB
RV-625
UMN-2001
Rotavac-5C
Others

Segment by Application
Clinic
Hospital
Others